Northwire Canada EditionWednesday, July 15, 2026
Sign inSubscribe
Northwire
⌕
SGML 15.86 −6.0% FURY 0.730 −2.7% CG 22.11 −1.9% ARIS 20.18 −1.1% LAF 1.65 +0.0% MKO 10.18 −2.2% NUG 0.330 −1.5% SGN 0.250 −5.7% AVL 7.99 −0.4% ELE 22.14 −2.7% TRX 1.03 −7.2% PTM 1.83 +0.6% OMM 0.050 −9.1% CBG 0.300 −1.6% GGA 6.30 +2.4% PRG 0.260 −3.7% SGML 15.86 −6.0% FURY 0.730 −2.7% CG 22.11 −1.9% ARIS 20.18 −1.1% LAF 1.65 +0.0% MKO 10.18 −2.2% NUG 0.330 −1.5% SGN 0.250 −5.7% AVL 7.99 −0.4% ELE 22.14 −2.7% TRX 1.03 −7.2% PTM 1.83 +0.6% OMM 0.050 −9.1% CBG 0.300 −1.6% GGA 6.30 +2.4% PRG 0.260 −3.7%
Financings

ROCKET DOCTOR AI INC. ANNOUNCES UPSIZE ON LISTED ISSUER FINANCING EXEMPTION (LIFE) NON-BROKERED PRIVATE PLACEMENT

By The Northwire Desk — AI Analysis Jan 19, 2026 · 18:04 AIDR · 0.81 Rocket Doctor AI Inc.
AIDR · Price

Executive Summary

  • Rocket Doctor AI Inc. upsized its non‑brokered private placement of units to a maximum of $5.2 million in gross proceeds.
  • Each unit is priced at $0.70, and all other terms of the offering remain unchanged from the prior announcements on Jan 9 2025 and Jan 16 2026.
  • The company filed an amended and restated offering document reflecting the increased size; proceeds are intended to fund ongoing operations and growth initiatives.

Key Details

  • Upsized Offering Size: Increased to a maximum of $5.2 million in gross proceeds.
  • Unit Price: $0.70 per unit (unchanged).
  • Units Offered: Non‑brokered private placement units (the “Units”).
  • Previous Announcements: Original private placement announced on January 9, 2025 and January 16, 2026.
  • Terms: All other terms of the offering remain unchanged from the prior disclosures.
  • Documentation: Amended and restated offering document filed and available via the company’s SEDAR profile (www.sedarplus.ca) and corporate website (www.rocketdoctor.ai).
  • Use of Proceeds: Not detailed in this release; referenced as “use of proceeds” in forward‑looking statements.
  • Regulatory Notices: The press release does not constitute an offer or solicitation in the United States; securities are not registered under the U.S. 1933 Act.

Notable Quotes

  • “We are pleased to announce this upsized private placement, reflecting strong investor demand and providing us with additional capital to accelerate our AI‑driven healthcare initiatives,” – Dr. Essam Hamza, CEO.
Read the original news release →

More from Rocket Doctor AI Inc.

Jun 30, 2026 · 08:00

Rocket Doctor Enters into a Primary Care Value-Based Care Agreement in the United States, Expanding In-Network Coverage by More Than 5 Million Members

M&A / Property Jun 23, 2026 · 08:00

AI-driven telemedicine platform expanding U.S. payer network, but burning cash with a going concern warning.

M&A / Property Jun 18, 2026 · 08:00

AI-driven telehealth platform scaling U.S. payer network, but burning cash and diluting equity to fund marketing.

M&A / Property Jun 16, 2026 · 08:00

AI-driven telehealth platform scaling U.S. payer access while burning cash to fund growth and R&D.

Other Jun 08, 2026 · 08:00

Rocket Doctor AI Launches a Strategic Marketing Partnership with Rick Ware Racing and FINTEKK AP for the 2026 NASCAR Cup Series, NHRA (National Hot Rod Association), World Supercross Championship, AFT (AMA - American Flat Track) and other Nationally telev

M&A / Property Jun 02, 2026 · 08:00

AI Virtual Care Platform Accelerates U.S. Visits and Secures Cash Runway, But Margin Compression and Going Concern Doubts Loom

Earnings